Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001867096-25-000089
Filing Date
2025-05-08
Accepted
2025-05-08 16:12:34
Documents
94
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xers-20250331.htm   iXBRL 10-Q 890426
2 EX-10.1 ex101-11x6x24xnonxemploy.htm EX-10.1 4413
3 EX-10.2 ex102-consultingagreemen.htm EX-10.2 15805
4 EX-31.1 a202510-qexhibit311.htm EX-31.1 10051
5 EX-31.2 a202510-qexhibit312.htm EX-31.2 9986
6 EX-32.1 a202510-qexhibit321.htm EX-32.1 7917
12 ex101-11x6x24xnonxemploy001.jpg GRAPHIC 170479
13 ex101-11x6x24xnonxemploy002.jpg GRAPHIC 119147
14 ex102-consultingagreemen001.jpg GRAPHIC 242552
15 ex102-consultingagreemen002.jpg GRAPHIC 286139
16 ex102-consultingagreemen003.jpg GRAPHIC 282833
17 ex102-consultingagreemen004.jpg GRAPHIC 235826
18 ex102-consultingagreemen005.jpg GRAPHIC 47818
19 ex102-consultingagreemen006.jpg GRAPHIC 24717
  Complete submission text file 0001867096-25-000089.txt   7922939

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20250331.xsd EX-101.SCH 48293
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20250331_cal.xml EX-101.CAL 73543
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20250331_def.xml EX-101.DEF 216236
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20250331_lab.xml EX-101.LAB 633506
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20250331_pre.xml EX-101.PRE 432748
97 EXTRACTED XBRL INSTANCE DOCUMENT xers-20250331_htm.xml XML 667350
Mailing Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607
Business Address 1375 WEST FULTON STREET, SUITE 1300 CHICAGO IL 60607 844-445-5704
Xeris Biopharma Holdings, Inc. (Filer) CIK: 0001867096 (see all company filings)

EIN.: 871082097 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40880 | Film No.: 25926224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)